Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 951 to 975 of 1160 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
210 increased hyperplasia (MESH:D006965) hepatic oval stem cell (CL:0002196) 854: Alterations, Cellular proliferation / hyperplasia
209 abnormal cell proliferation (GO:0008283) Liver cell (FMA:63179) 854: Alterations, Cellular proliferation / hyperplasia
208 occurrence Liver Diseases (MESH:D008107) 139: N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects
207 decreased apoptotic process (GO:0006915)
206 abnormal cellular homeostasis (GO:0019725) 853: Changes/Inhibition, Cellular Homeostasis and Apoptosis
205 increased signaling (GO:0023052) aryl hydrocarbon receptor (PR:000003858) 165: Activation, Long term AHR receptor driven direct and indirect gene expression changes
204 increased cell proliferation (GO:0008283) memory T cell (CL:0000813) 272: Activation/Proliferation, T-cells
203 increased T cell activation (GO:0042110) T cell (CL:0000084) 272: Activation/Proliferation, T-cells
202 increased MHC protein complex assembly (GO:0002396) 398: Activation, Dendritic Cells
201 increased cell activation (GO:0001775)
200 increased cytokine production involved in inflammatory response (GO:0002534) 826: Activation, Keratinocytes
199 increased keratinocyte activation (GO:0032980) 826: Activation, Keratinocytes
198 increased protein binding (GO:0005515) electrophilic reagant (CHEBI:59739) 396: Covalent Binding, Protein
197 increased Respiratory Hypersensitivity (MESH:D012130) 313: Increase, Allergic Respiratory Hypersensitivity Response
196 increased cytokine activity (GO:0005125) Cytokine (FMA:84050) 151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways
195 increased chemokine activity (GO:0008009) Chemokine (FMA:241981) 151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways
194 increased covalent binding (MI:0195) xenobiotic (CHEBI:35703) 75: N/A, Covalent binding to protein, possibly lysine residue
193 increased transforming growth factor beta1 production (GO:0032905) TGF-beta 1 (PR:000000182) 276: Up Regulation, TGFbeta1 expression
192 occurrence liver fibrosis (MP:0003333) liver (UBERON:0002107)
191 increased macrophage activation (GO:0042116) Kupffer cell (CL:0000091) 134: Increase, Kupffer cell activation
190 increased protein alkylation (GO:0008213) 244: Alkylation, Protein
189 increased hepatic stellate cell activation (GO:0035733) hepatic stellate cell (CL:0000632) 265: Increase, Hepatic stellate cell activation
188 increased collagen biosynthetic process (GO:0032964) collagen (CHEBI:3815) 68: Increase, Collagen accumulation
187 increased fatty liver (MESH:D005234) None
186 decreased 3-hydroxyacyl-CoA dehydrogenase activity (GO:0003857) 3-hydroxyacyl-CoA dehydrogenase type-2 (PR:000008774)